Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis
NCT02718677
·
clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Company decision to not conduct study
Conditions
Hemophilia A
Interventions
DRUG:
Refacto AF
Sponsor
Pfizer